Dublin, Calif. – April 3, 2023 – Azure Biosystems will be exhibiting at the 2023 Annual Meeting of the American Association for Cancer Research (AACR) in Orlando, FL at the Orange County Convention Center. This will be Azure’s first attendance at the event since 2019. The Azure team will be led by Tram Tran (Associate Marketing Manager), Vanna Sombatsaphay (Application Scientist, qPCR), and Justin Menko (Technical Product Specialist), who are excited to show meeting attendees Azure’s complete line of imaging and qPCR products.
Visit the team at booth #304 to see how easy gel imaging and densitometry can be with Azure’s brand-new personal chemiluminescence imager, the chemiSOLO. Also on display will be the new Sapphire FL Biomolecular Imager, a flexible imaging system with completely customizable and user-changeable optical modules. The Sapphire FL is compatible with nearly any imaging application, from gels and blots, to slides and small living animals, thanks to the addition of five anesthesia ports. Other flagship products from Azure that will be on display include the Cielo qPCR system, as well as the Azure Imaging Systems; all products will be available for in-person demos. The 2023 AACR Annual Meeting takes place April 14-19, 2023.
Is your AACR schedule quickly filling up? Schedule a meeting with someone from our team to make sure you don’t miss out! Schedule your meeting time here.
About Azure Biosystems
Azure Biosystems Inc. is an innovative life science platform company that designs, develops and markets state-of-the-art instruments, including the Azure Imaging Systems and the Azure Cielo Real-time PCR system. Azure Biosystems’ experienced team has developed 2nd and 3rd generation imaging systems for the life science market, thus applying their technical and market knowledge in creating innovative industry standard setting platforms.